Angela Fraddosio

Bari, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Unrevealing the sequence of dysphagia progression in ALS: an event-based, FEES-driven staging approach.

Unrevealing the sequence of dysphagia progression in ALS: an event-based, FEES-driven staging approach.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: September 28, 2025

Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes.

Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes.

Journal: Biomedicines
Published: July 29, 2023

A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.

A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis.

Journal: Biomedicines
Published: June 26, 2023

Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics.

Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics.

Journal: AJNR. American journal of neuroradiology
Published: September 20, 2022

Medulla oblongata volume as a promising predictor of survival in amyotrophic lateral sclerosis.

Medulla oblongata volume as a promising predictor of survival in amyotrophic lateral sclerosis.

Journal: NeuroImage. Clinical
Published: October 11, 2021

Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience.

Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience.

Journal: Clinical drug investigation
Published: July 27, 2021

King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis.

King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis.

Journal: Journal of the neurological sciences
Published: May 26, 2021

Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-report.

Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-report.

Journal: Clinical case reports
Published: April 30, 2021

Subclinical upper motor neuron involvement at the diagnosis may predict disease progression in a cohort of lower motor neuron syndromes from Southern Italy.

Subclinical upper motor neuron involvement at the diagnosis may predict disease progression in a cohort of lower motor neuron syndromes from Southern Italy.

Journal: Journal of the neurological sciences
Published: January 18, 2021

Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone.

Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone.

Journal: Journal of neurology
Published: January 01, 2021

Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?

Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?

Journal: Muscle & nerve
Published: September 25, 2020

Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype.

Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype.

Journal: Journal of neurology
Published: May 15, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026